Biospring Partners
Signal active
Investment Firm
Overview
Biospring Partners is a growth equity firm that invests in Life Sciences Technology. Biospring leverages its deep experience in life sciences and technology to support B2B services, tools, and enterprise software companies that are driving innovation across the life sciences industry and beyond.
Highlights
Founded
2020
Industry
Information Technology
Employees
1-10
Investment
6
Lead Investment
3
Exits
3
Stages
Early Stage Venture, Private Equity, Late Stage Venture
Investor Type
Private Equity Firm, Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Biospring Partners, established in 2020 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Private Equity, Late Stage Venture investments across E-Commerce, Marketplace, Life Science, Health Care, Financial Services, Venture Capital, Finance, FinTech, Business Development, Enterprise Software. The organization boasts a portfolio of 6 investments, with an average round size of $67.0M and 3 successful exits. Their recent investments include Labviva, B Capital, Glasswing Ventures, Senator Investment Group, Abzena. The highest investment round they participated in was $46.0B. Among their most notable exits are Labviva and B Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Biospring Partners has made 6 investments. Their most recent investment was on Mar 27, 2023, when Labviva raised $20.0M.
investments
6
Diversity investments
0
Lead investments
3
Number of exits
3
Investments
6
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 18, 2021 | PathAI | Biotechnology | 165.0M |
| Nov 10, 2021 | KINICITI | Venture Capital | null |
| Mar 31, 2022 | Abzena | Biotechnology | 65.0M |
| Mar 27, 2023 | Labviva | E-Commerce | 20.0M |
Exits
3
Funding Timeline
Funding rounds
6
Investors
0
Funds
1
Funding Rounds
6
Biospring Partners has raised 6 rounds. Their latest funding was raised on Mar 27, 2023 from a Series A - Labviva round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 18, 2021 | Series C - PathAI | - | 165.0M | - |
| Nov 10, 2021 | Venture Round - KINICITI | - | 0 | - |
| Mar 31, 2022 | Private Equity Round - Abzena | - | 65.0M | - |
| Mar 27, 2023 | Series A - Labviva | - | 20.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.